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Flavonoid supplementation improves brachial artery flow-mediated dila-
tion (FMD), but it is not known whether flavonoids protect against
vascular dysfunction induced by ischemia-reperfusion (IR) injury and
associated respiratory burst. In a randomized, double-blind, placebo-
controlled, crossover study, we investigated whether 4 wk supplementa-
tion with freeze-dried Montmorency cherry (MC) attenuated suppression
of FMD after IR induced by prolonged forearm occlusion. Twelve
physically inactive overweight, middle-aged men (52.8 5.8 yr, BMI:
28.1 5.3 kg/m2) consumed MC (235 mg/day anthocyanins) or placebo
capsules for 4 wk, with supplementation blocks separated by 4 wk
washout. Before and after each supplementation block, FMD responses
and plasma nitrate and nitrite ([NO2]) concentrations were measured at
baseline and 15, 30, and 45 min after prolonged (20 min) forearm
occlusion. FMD response was significantly depressed by the prolonged
occlusion (P 0.001). After a 45-min reperfusion, FMD was restored to
baseline levels after MC (FMD presupplementation: 30.5 8.4%,
postsupplementation: 0.6 9.5%) but not placebo supplementation
(FMD presupplementation: 11.6 10.6, postsupplementation:
25.4 4.0%; condition supplement interaction: P 0.038). Plasma
[NO2] decreased after prolonged occlusion but recovered faster after MC
compared with placebo (45 min to baseline; MC: presupplementation:
15.3 9.6, postsupplementation:6.2 8.1; Placebo: presupplemen-
tation: 16.3 5.9, postsupplementation: 27.7 11.1 nmol/l; condi-
tion supplement time interaction: P 0.033). Plasma peroxiredoxin
concentration ([Prx2]) was significantly higher after MC (presupplemen-
tation: 22.8 1.4, postsupplementation: 28.0 2.4 ng/ml, P  0.029)
but not after placebo supplementation (presupplementation: 22.1 2.2,
postsupplementation: 23.7 1.5 ng/ml). In conclusion, 4 wk MC sup-
plementation enhanced recovery of endothelium-dependent vasodilata-
tion after IR, in parallel with faster recovery of plasma [NO2], suggesting
NO dependency. These protective effects seem to be related to increased
plasma [Prx2], presumably conferring protection against the respiratory
burst during reperfusion.
NEW & NOTEWORTHY This is the first study to demonstrate that
4 wk of Montmorency cherry powder supplementation exerted pro-
tective effects on endothelium-dependent vasodilation after transient
ischemia-reperfusion injury in overweight, physically inactive, non-
medicated, hypertensive middle-aged men. These effects seem to be
due to increased nitric oxide availability, as evidenced by higher
plasma nitrite concentration and peak arterial diameter during the
flow-mediated dilation measurement. This may be a consequence of
increased concentration of peroxiredoxin and other antioxidant sys-
tems and, hence, reduced reactive oxygen species exposure.
endothelial function; forearm occlusion; Montmorency cherry; nitrite/
nitrate; peroxiredoxin-2
INTRODUCTION
Cardiovascular diseases (CVD) remain the leading worldwide
cause of death with an estimated 17.3 million deaths in 2008,
which is projected to increase to 23 million by 2030 (27). Higher
consumption of fruit and vegetables is associated with a lower risk
of all-cause mortality, particularly cardiovascular disease mortal-
ity (43). Epidemiological data suggest that polyphenols within
fruits and vegetables may contribute to this observed reduction in
CVD risk (4, 13). Specifically, a systematic review of prospective
cohort studies found that the dietary intake of different classes of
flavonoids, including flavonols, flavones, flavanones, flavan-3-ols,
anthocyanidins, and proanthocyanidins significantly decreased the
risk of CVD (44). Risk factors for CVD, including hypertension,
hypercholesterolemia, and diabetes mellitus are associated with
enhanced production of reactive oxygen species (ROS), particu-
larly superoxide, generated by enzymes such as xanthine oxidase
and NADPH oxidase (NOX) and via the electron transport chain,
which induce endothelial dysfunction and oxidative stress in the
vascular wall (29). Ischemia-reperfusion injuries are relatively
common vascular events during general surgical procedures, and
they present a significant problem for organ transplant. For in-
stance, myocardial injury was experienced by 19% of individuals
aged over 45 yr after noncardiac surgery in vascular surgical
patients, with the majority of these events clinically silent (7).
Despite this incidence level, and the significant tissue damage
resulting from ischemia-reperfusion leading to irreversible patho-
physiology, such as myocardial infarction and stroke, the avail-
ability and efficacy of therapeutic strategies are still poor.
Rodriguez-Mateos et al. (38) found that acute blueberry
supplementation (766 mg of total polyphenols) increased flow-
mediated dilation (FMD) in healthy young men, peaking 1 and
6 h postconsumption, which paralleled the reduction in neu-
trophil NOX activity. Acute Montmorency cherry (MC) con-
sumption (74 mg anthocyanin, 179 mg total polyphenols)
significantly lowered systolic blood pressure in tandem with
increases in circulating phenolic acids (22). A number of
studies have also found improvements in endothelium-depen-
dent vasodilation after chronic supplementation with fruit poly-
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phenols, especially among study populations with impaired
cardiovascular function. Grape juice supplements have been
shown to improve FMD in patients with coronary artery
disease (56 days) (14) and patients with hypercholesterolemia
(14 days) (16). Red grapes (72 g/day for 21 days) reduced the
suppression of FMD induced by a high-fat meal (13), grape
polyphenols improved FMD in patients with metabolic syn-
drome (267 mg polyphenols for 30 days) (6) and grape seed
extract (2 g/day for 4 wk) improved FMD in patients with
increased CVD risk (15). Chokeberry juice supplementation (1
g polyphenols/day) for 6 wk also increased FMD in patients
with hypercholesterolemia (36), and Khan et al. (24) found that
black currant polyphenol supplementation for 6 wk (815 mg
polyphenols, including 143 mg anthocyanins per day) im-
proved FMD in healthy adults consuming two or fewer por-
tions of fruit and vegetables per day. Consumption of blue-
berry, cherry, cacao, and black currant polyphenols appear to
enhance vascular function (19, 22, 24, 38), most likely through
reduced ROS exposure and, hence, increased NO bioavailabil-
ity (40, 47). Although, not all studies have shown favorable
effects, for example, chronic supplementation (2–6 wk) with
grapeseed extract (0.6–1.0 g/day) had no effect on FMD in
patients with Type 2 diabetes (23), participants with elevated
CVD risk (although baseline brachial artery diameter was
increased) (36), and healthy young men (37).
To date, only one study has investigated whether polyphenol
supplementation preserved endothelium-dependent vasodilata-
tion after exposure to prolonged forearm occlusion in healthy
adults (39). Schreuder et al. (39) found that after a 7-day period
consuming three cups of black tea per day (~900 mg total
polyphenols) FMD was enhanced 90 min after consumption of
~600 mg black tea polyphenols, but FMD was not preserved 20
min after prolonged forearm occlusion. However, prior chronic
supplementation with both blueberry polyphenols (2) and
cherry polyphenols (5) reduced ischemia-reperfusion (IR)-
induced infarct size, better preserved cardiac function, and
protected against postischemic cardiac remodeling in isolated
rat hearts. Collectively, these data suggest that a longer period
of cherry or berry polyphenol supplementation may be neces-
sary to provide vasoprotection against IR injury or that effects
may be more likely to be observed in a study population with
elevated cardiovascular risk factors. Therefore, we hypothe-
sized that 4 wk of Montmorency cherry supplementation would
increase endogenous antioxidant capacity and, thus, improve
FMD and protect against the impairment in endothelial-depen-
dent vasodilation induced by ischemia reperfusion. We ad-
opted an experimental model of a prolonged (20-min) occlu-
sion of the forearm that induces a short-lasting impairment to
FMD (14, 31) and provides an in vivo model of transient IR
injury. We recruited a nonmedicated, physically inactive, over-
weight, hypertensive, middle-aged male population to take part
in the study.
MATERIALS AND METHODS
Participants. Twelve physically inactive, middle-aged male partic-
ipants (age: 52.8 5.8 yr, BMI: 28.1 5.3 kg/m2; Table 1) com-
pleted the trials, from a total of 14 participants recruited by Z.
Aboo-Bakkar from local residents in Devon, UK. All participants
were nonsmokers, with no known history of diabetes, cardiovascular
diseases, or bone or joint problems, and they were not taking any
drugs or nutritional supplements, as assessed by questionnaires. Ha-
bitual physical activity was assessed using the International Physical
Activity Questionnaire, and if participants reported 150 min/week
moderate or vigorous activity, they were deemed to have met the
physically inactive inclusion criterion. The study was approved by the
University of Exeter Research Ethics Committee (2013/409) and
conformed with the Declaration of Helsinki. All participants provided
their written informed consent before taking part. Two participants
withdrew from the study after baseline measurements were com-
pleted, but before commencing supplementation.
Study design. The study used a double-blind, randomized crossover
design with two experimental arms and a washout period of 4 wk
(Fig. 1). Each of the participants was randomly assigned by J. L.
Bowtell using a sealed opaque envelope system to receive either MC
capsules in the first supplementation block followed by placebo or
vice versa and were scheduled to attend the laboratory for four trial
visits. Participants and the research team involved in performing the
data analysis remained blind to treatment until all analyses were
completed. Baseline measurements before each supplementation
block were made during visits 1 and 3, followed by the 4-wk
supplementation blocks, and postsupplementation measurements were
made in visits 2 and 4. The participants consumed either 1.7 g MC
powder per day for 28 days in the form of six capsules (226 mg
anthocyanins and 456 mg total phenolics measures as gallic acid
equivalents, CherryActive, Sunbury, UK) or placebo capsules (glu-
cose). Three capsules were consumed in the morning and three in the
evening, with the last dose taken on the evening before the postsupple-
Fig. 1. Schematic diagram of study design.
Table 1. Participant characteristics
Parameter Value
Age, yr 54 1
Height, cm 179 1
Weight, kg 91.5 4.0
Body mass index, kg/m2 28.2  1.6
Resting heart rate, beats/min 66 0
Systolic blood pressure, mmHg 142 6
Diastolic blood pressure, mmHg 88 3
Values are expressed as means  SE.
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mentation measures. In line with previous studies (10, 21, 42), there
was at least a 4-wk washout period between trials.
Experimental protocol. Participants reported to the laboratory at
8:00 AM on each visit, preceded by an overnight fast (10 h) and
having abstained from alcohol and caffeine for more than 24 h.
Participants were asked to avoid food and beverages containing high
phenolic compounds and record their diet for two consecutive days
immediately before their first laboratory visit and to replicate this for
2 days before subsequent visits. Diet diaries were analyzed using
Nutritics software, and data are presented in Table 2. Upon arrival, a
cannula was placed in the antecubital vein of the left arm, the same
arm upon which FMD measurements were made. Trials were con-
ducted in a quiet room with dim light and room temperature set at
24°C. Participants rested in a supine position for 10 min, before
baseline FMD was assessed in the left arm with the cuff placed just
below the elbow. Fifteen minutes after the baseline FMD measure-
ment, the cuff was inflated to 200 mmHg (Hokanson, Bellevue, WA)
for 20 min to induce transient ischemia, and then FMD measures were
repeated after 15, 30, and 45 min of reperfusion. Venous blood
samples were obtained at baseline, immediately, 2, 4, 15, 30, and 45
min after the 20-min occlusion (Fig. 2). Blood samples at 15, 30, and
45 min were collected immediately after cuff release for FMD
measurement. Samples were centrifuged at 4,000 rpm and 4°C for 10
min, within 1 min of collection. Plasma was subsequently extracted
and immediately frozen at 80°C for later analysis for nitrite (NO2),
nitrate (NO3), IL-6, C-reactive protein (CRP), protein carbonyl (PC),
peroxiredoxin 2 (Prx2) content, and catalase (CAT) activity.
Brachial artery FMD. Brachial artery FMD was examined in the
left arm, with the arm extended and positioned at an angle of ~80°
from the torso. Three ECG electrodes were positioned on the left and
right intraclavicular fossa and left iliac crest region, respectively. A
high-resolution ultrasonography system (Sequoia 512, Acuson; Sie-
mens, Munich, Germany) with a 13-MHz linear array transducer was
used to image the brachial artery in the distal one-third of the upper
arm in accordance with the established protocol in our laboratory (8,
9) and recent guidelines (41). To ensure arm stability and transducer
placement, a customized arm rest and transducer holder device cra-
dled the arm and locked the transducer in the position, providing the
optimal image of the brachial artery. Ultrasound parameters were set
to optimize the longitudinal B-mode images of the lumen–arterial wall
interface and were then held stable for a 1-min baseline recording of
the image and Doppler velocity. Continuous Doppler velocity assess-
ment was collected using a 60° insonation angle, which did not vary
during each study. The occlusion cuffs were inflated to 250 mmHg to
completely block the arterial inflow for 5 min. Diameter and flow
recordings resumed 30 s before cuff deflation and continued for 3 min
thereafter. All FMD analyses were performed by the same investigator
who was blind to the condition. Ultrasound images triggered at the
beginning of the R-wave, which marks the end of the diastolic phase,
were captured and then analyzed off-line using a validated ECG-
gating software (Brachial Analyzer, five vascular devices; Medical
Imaging Applications, Coralville, IA). The region of interest was
carefully defined and frame-by-frame analysis of artery diameter
(mm), and blood flow velocity (m/s) was performed by the same
analyst. Baseline diameter was calculated as the mean of the artery
diameter from a 1-min baseline recording before each cuff inflation.
Peak diameter was determined as the highest artery diameter mea-
surements after each cuff deflation. Endothelium-dependent vasodila-
tion was calculated as the percentage increase in arterial diameter after
a 5-min ischemic stimulus. The total shear rate under the curve (SR
AUC) was calculated as the area under the shear curve versus time
immediately after cuff deflation until peak arterial diameter (41).
Plasma nitrite and nitrate concentration. All glassware, utensils,
and surfaces were rinsed with deionized water to remove residual
[NO2] and [NO3] before blood analyses. The undiluted (nondepro-
teinized) and deproteinized plasma was used to analyze [NO2] and
[NO3], respectively, using a Sievers gas-phase chemiluminescence
NO analyzer (NOA; Sievers NOA 280i; Analytix, Durham, UK) as
described in previous studies (45, 46).
Plasma Prx2 concentration and CAT activity. Plasma was diluted
16-fold and analyzed for [Prx2] using a commercial ELISA kit,
according to the manufacturer’s instructions (Cloud-Clone, Katy,
TX). For CAT activity, plasma was diluted five-fold and analyzed
using a commercial ELISA kit, according to the manufacturer’s
instructions (Cayman Chemical, Ann Arbor, MI).
Plasma CRP and IL-6 concentration. Plasma [CRP] was deter-
mined using a turbidometric assay on a Siemens Advia 2400 auto-
analyzer and using commercially available reagents (PZ Cormay,
Lublin, Poland). Plasma [IL-6] was assessed using a commercially
available ELISA kit (IBL International, Hamburg, Germany).
Plasma PC concentration. Protein content in all plasma samples
were measured using NanoDrop Lite (Thermo Fisher Scientific,
Wilmington, DE). Each plasma sample was diluted to 10 g/ml of
protein in 1 PBS. The OxiSelect protein carbonyl ELISA kit
(STA-310; Cell Biolabs, San Diego, CA) was used to measure
protein carbonyls. Briefly, samples were allowed to adsorb to wells
of a 96-well plate and then reacted with dinitrophenol hydrazine.
The protein carbonyls derivatized to dinitrophenyl hydrazone
(DNP) were then probed with an anti-DNP antibody. The standard
curve was prepared from commercially prepared reduced and
oxidized BSA standards as provided.
Statistical analysis. Sample size was based on the power curves for
the use of FMD in crossover designs reported by Donald et al. (16)
and the effect size reported by Khan et al. (24) after polyphenol
supplementation. With 80% power, 5% significance, and an effect size
Table 2. Average dietary composition
Dietary Composition Value
Energy, kcal/day 1883 115
Protein, g/day 74.6 4.1
Protein, g·kg1·day1 0.9  0.1
Carbohydrate, g/day 237.8 29.9
Fat, g/day 66.9 5.5
Total cholesterol, mg/day 328.5 48.0
Saturated fat, g/day 23.2 3.1
Dietary fiber, g/day 16.3 2.2
Sugars, g/day 77.5 22.4
Values are expressed as means SE. Average dietary composition for the
48-h period before each trial.
Fig. 2. Brachial artery flow-mediated dila-
tion (FMD) and venous blood collection be-
fore and after prolonged occlusion protocol
to induce transient ischemia-reperfusion in-
jury. Arrows represent FMD measurements
and blood samples for plasma analysis.
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of 0.8 for increase in FMD (24), 12 participants are required in each
group. All data are presented as means SE. FMD, baseline and peak
brachial artery diameter, SR AUC, and plasma [NO2] and [NO3]
were analyzed by three-way, repeated-measures ANOVA: condition
(MC  placebo) by supplement (presupplementation  postsupple-
mentation) by time (FMD measures: baseline, 15, 30, and 45 min
postocclusion; plasma nitrate and nitrite measures: baseline, 0, 2, 4,
15, 30, and 45 min postocclusion). Targeted post hoc two-way
repeated-measures ANOVA were completed where significant three-
way interaction effects were identified. Baseline plasma [CRP], [IL-
6], [PC], [Prx2], and CAT activity before and after each supplemen-
tation block were analyzed by two-way repeated-measures ANOVA.
Mauchly’s sphericity test was used to check the homogeneity of
variance for all ANOVA analyses; when necessary, violations of the
assumption were corrected with the use of the Greenhouse-Geisser
adjustment. Significant main effects were followed up with the use of
least significant difference post hoc analysis. Data were analyzed
using statistical software (SPSS version 19; IBM; New York), with
significance accepted as P  0.05.
RESULTS
Brachial artery FMD. There were no significant differences
in baseline FMD values for the four measurement visits. The
FMD response was significantly depressed by the prolonged
occlusion in all visits (main effect of time: P 0.001; Fig. 3A)
with a significant reduction in FMD 15 and 30 min postocclu-
sion, but FMD was not significantly different to baseline 45
Fig. 3. Flow-mediated dilation (FMD; A and B), baseline diameter (C and D), and peak diameter (E and F) before and after prolonged occlusion for placebo (A,
C, and E) and Montmorency cherry (MC; B, D, and F) conditions. Values are expressed as means SE; n  12. *Significant difference from baseline (main
effect for time, P  0.05). #Condition vs. supplementation vs. time interaction, P  0.05.
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min after prolonged occlusion. There was a significant
condition  supplementation  time interaction (P  0.022),
whereby 45 min after prolonged occlusion, the FMD response
was reduced after placebo supplementation but better preserved
after MC supplementation (Fig. 3B). Specifically, the magnitude
of FMD suppression 45 min after the prolonged occlusion
(change from baseline FMD to 45 min postocclusion) was signif-
icantly attenuated after MC (pre: 30.5 8.4% vs. post:
0.6 9.5%) compared with placebo (pre: 11.6 10.6 vs.
post: 25.4 4.0) supplementation (condition  supplementa-
tion interaction: P  0.038). Similarly, there was a reduction in
SR AUC (main time effect: P  0.001; Table 3) after prolonged
occlusion, but there was no condition or supplementation effect.
Normalization of the FMD data to SR AUC (FMD:SR AUC) did
not affect the outcome of the analysis (Table 3). Peak brachial
artery diameter was significantly suppressed after prolonged oc-
clusion (main time effect, P  0.001). There was a condition 
supplementation  time interaction (P  0.011; Fig. 3D),
whereby peak diameter was higher following prolonged occlusion
post- versus pre-MC supplementation but not post- versus pre-
placebo supplementation. In contrast, basal diameter of the bra-
chial artery (immediately before occlusion for FMD measure-
ment) was increased after the prolonged occlusion (main time
effect, P  0.001; Fig. 3C), but there was no condition or
supplementation effect.
Plasma analytes. Plasma [NO2] and [NO3] were signifi-
cantly depressed by the prolonged occlusion in all visits (main
effects of time, P  0.001; Table 4). Plasma [NO2] returned
toward baseline during the 45-min recovery after prolonged
occlusion more quickly after MC supplementation compared
with placebo (condition supplement time interaction, P
0.033; Fig. 4, A and B). There was no significant effect of
supplementation on plasma [NO3]. Basal plasma [Prx2] was
higher after MC (P  0.029) but not after placebo supplemen-
tation (Fig. 5A). However, there was no effect of supplemen-
tation on basal plasma CAT activity (P 	 0.05; Fig. 5B), or
plasma [CRP], [IL-6], and [PC] (P 	 0.05, Table 5).
DISCUSSION
Four weeks of MC supplementation enhanced recovery of
endothelium-dependent vasodilation in overweight, physically
inactive, nonmedicated hypertensive, middle-aged men after
the transient ischemia-reperfusion injury induced by prolonged
Table 3. Shear rate area under the curve and FMD normalized to SR AUC
Time
Baseline 15 min Post 30 min Post 45 min Post
SR AUC*
Placebo
Pre 663 91 623 63 594 75 629  68
Post 683 101 533 60 550 52 579  85
Montmorency cherry
Pre 669 85 525 58 524 47 577  64
Post 632 63 456 54 444 57 544  63
FMD:SR AUC*
Placebo
Pre 0.99 0.16 0.46 0.06 0.66 0.12 0.85  0.12
Post 1.00 0.13 0.67 0.13 0.75 0.10 0.92  0.15
Montmorency cherry
Pre 0.90 0.09 0.49 0.07 0.65 0.10 0.70  0.11
Post 1.06 0.22 0.61 0.09 1.11 0.29 1.15  0.20
Values are expressed as means SE. Shear rate area under the curve (SR AUC) and flow-mediated dilation (FMD) were normalized to SR AUC (FMD:SR
AUC) measured 15 min before 20-min occlusion (baseline), 15, 30, and 45 min after reperfusion and before and after each supplementation block. *Main effect
of time, P  0.001.
Table 4. Plasma nitrite [NO2] and nitrate [NO3] concentrations
Baseline Time 0, min Post Time 2, min Post Time 4, min Post Time 15, min Post Time 30, min Post Time 45, min Post
[NO2], nmol/l*#
Placebo
Pre 87.3 7.6 63.5  4.2 70.9  3.4 68.3  4.8 72.8 10.8 69.0  5.7 71.0  7.4
Post 104.2 13.5 91.3 9.7 86.2  9.1 83.8  11.3 88.7 7.6 82.3  6.5 76.5  6.9
MC
Pre 82.1 10.0 80.7 11.1 74.2  11.3 71.9  10.1 68.2 14.9 64.2  11.8 66.8  10.1
Post 83.2 10.5 65.6 7.3 77.7  8.6 70.2  6.4 81.1 7.3 74.2  9.4 77.0  10.7
[NO3], mol/l*
Placebo
Pre 32.8 3.9 29.7  3.6 28.6  3.5 28.7  3.3 27.7 2.9 27.9  2.9 27.2  3.0
Post 27.3 2.6 25.7  3.0 26.8  3.3 25.9  2.4 25.7 2.7 24.4  2.8 25.8  2.7
MC
Pre 27.6 4.9 24.8  4.4 26.2  4.7 25.8  4.8 25.6 4.6 25.0  4.5 24.7  4.1
Post 29.5 5.2 28.2  4.9 29.3  4.9 27.9  4.9 26.8 4.7 26.6  4.4 26.3  4.4
Values are expressed as means SE. Plasma [NO2] and [NO3] measured 15 min before 20-min occlusion (baseline), and immediately, 2, 4, 15, 30, and 45
min after reperfusion, before, and after placebo or Montmorency cherry (MC) supplementation. *Main effect of time P  0.001. #Three-way interaction effect.
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forearm occlusion. Plasma nitrite concentration was higher
after MC supplementation during the recovery period after
ischemia. Moreover, plasma peroxiredoxin 2 concentration
was increased after 4 wk MC supplementation, indicating
increased capacity for reduction of hydrogen peroxide and,
therefore, superoxide quenching. This supports the notion that
MC supplementation enhanced NO bioavailability and vascu-
lar function under conditions of increased ROS generation after
prolonged blood flow occlusion via increased endogenous
antioxidant capacity.
Prolonged forearm occlusion induced transient IR injury as
evidenced by attenuated endothelium-dependent vasodilation.
DeVan et al. (14) reported that FMD in middle-aged sedentary
subjects was decreased by 68% by the same occlusion protocol
employed in the present study, while Schreuder et al. (39) and
Rakobowchuk et al. (37) reported 33% and 36% reductions in
FMD 15 min after prolonged occlusion in 8 healthy women
and 20 healthy older adults, respectively. In the present study,
the reduction in FMD after prolonged occlusion appears to be
reproducible across trials with FMD ~53% lower, 15 min after
prolonged occlusion when compared with baseline (52  19%,
pre-MC; 58  13%, pre-placebo; 49  21%, post-placebo;
and 55  17%, post-MC, respectively). In the present study,
the reduction in FMD after prolonged occlusion appears to be
reproducible across trials with FMD ~53% lower, 15 min after
prolonged occlusion when compared to baseline (52  19 %,
pre-MC; 58 13 %, pre-placebo; 4921 %, post-placebo; and
5517 %, post-MC, respectively). The FMD reduction after
prolonged occlusion seems to be a consequence of both in-
creased baseline artery diameter (12, 37, 39) and reduced peak
artery diameter (25, 37). It has been suggested that this im-
paired endothelium-dependent vasodilation is due to reduced
NO bioavailability as a consequence of increased ROS pro-
duction during reperfusion (17, 35). Our data are consistent
with this hypothesis, since plasma nitrate and nitrite concen-
trations were lower in the venous blood exiting the forearm
subjected to prolonged occlusion. Under normal resting con-
ditions, the rate of superoxide production is lower than the flux
of NO, and this allows effective scavenging of the low intra-
cellular levels of hydrogen peroxide and superoxide by anti-
oxidant systems, including PRX2, as well as by NO, resulting
in low levels of the cytotoxic derivative, peroxynitrite (18).
However, during reperfusion immediately after prolonged oc-
clusion, superoxide production is increased (35, 42), resulting
in greater peroxynitrite formation (30) and reduction in NO
Fig. 4. Change from baseline in plasma ni-
trite concentrations after prolonged occlu-
sion performed pre- and post- 4 wk of pla-
cebo (A) and Montmorency cherry (MC) (B)
supplementation. Values are expressed as
means  SE; n  9. #Condition  supple-
ment  time interaction, P  0.05.
Fig. 5. Baseline plasma peroxiredoxin 2 [Prx2] (A) and catalase (CAT) activity
(B) before and after prolonged occlusion performed pre and post 4 wk of
placebo and Montmorency cherry (MC) supplementation. Values are ex-
pressed as means  SE; n  12. ¥ denotes supplemental effect, P  0.05.
Table 5. Plasma biomarkers
Placebo Montmorency Cherry
Pre Post Pre Post
Interleukin-6,
pg/ml
0.06  0.04 0.06 0.06 0.06 0.03 0.07 0.09
C-reactive protein,
mg/l
1.01  0.33 3.90 2.69 1.90 0.40 3.40 1.27
Protein carbonyl,
nmol/mg
0.86  0.11 0.69 0.18 0.93 0.17 0.71 0.10
Values are expressed as means SE. Baseline plasma biomarkers before
and after 4 wk of Montmorency cherry and placebo supplementation.
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availability (34, 35). We cannot exclude the possibility that the
reduced pH and PO2 induced by ischemia enhanced degrada-
tion of nitrite to NO (32, 33), which may also contribute to the
reduction in plasma nitrite concentration observed in the pres-
ent study.
Fruit-derived polyphenols improve endothelium-dependent
vasodilatation; for instance, FMD response peaked between 1
and 2 h, and 6 h after consuming 766 mg of blueberry
polyphenols [310 mg anthocyanins (38)]. Keane et al. (22)
showed that systolic blood pressure (SBP) was significantly
lowered in hypertensive men (SBP  130 mmHg) 2 h after
ingestion of 60 ml of MC concentrate (74 mg cyanidin-3-
glucoside/l, 179 mean gallic acid equivalent/l). Chronic sup-
plementation interventions of 4 to 6 wk with fruit juice or
powder (32–143 mg anthocyanins/day) increased FMD re-
sponse in men with mild hypercholesterolemia (36) and met-
abolic syndrome (6), as well as men and women with low fruit
and vegetable intake (2 portions/day) (24). However, in the
present study, 4 wk of MC powder supplementation providing
256 mg/day anthocyanins (split into two doses, morning and
evening) did not improve FMD response in overnight fasted,
overweight, physically inactive, nonmedicated hypertensive
middle-aged men. Collectively, our findings and previous lit-
erature suggest that resting vascular function is only improved
after chronic fruit-based supplement consumption in those with
clinical conditions or low habitual polyphenol intake, but not in
those with elevated CVD risk factors. However, MC supple-
mentation was able to protect the vasculature from the decline
in endothelium-dependent vasodilation induced by ischemia
reperfusion in the present study. Polyphenols are suggested to
increase calcium-dependent endothelium nitric oxide synthase
(eNOS) phosphorylation through the phosphatidylinositol 3-ki-
nase-Akt pathway (3), thus enhancing NO production. Pheno-
lic metabolites such as vanillic acid have also been shown in
vivo to inhibit NOX activity in neutrophils (38). The resulting
reduction in superoxide production and, hence, reduced NO
degradation to peroxynitrite will also improve NO bioavail-
ability. Anthocyanins and their metabolites have been shown to
interact with cysteine residues present in Kelch-like ECH-
associated protein 1 (Keap1), resulting in nuclear translocation
and phosphorylation of Nrf2 (20, 26, 28), with subsequent
signaling through the antioxidant response element pathway to
increase production of downstream phase II antioxidant en-
zymes, such as the peroxiredoxins (1). The increased plasma
PRX2 concentration observed after MC supplementation is
consistent with this mechanism and suggests that enhanced
capability to quench ROS may contribute to the improved NO
bioavailability evident in the present study.
Prolonged forearm occlusion resulted in elevated baseline
diameter in all trials in this and previous studies (12, 37, 39).
This basal dilation might be related to increased endothelium-
derived hyperpolarizing factor production since this pathway is
upregulated during eNOS dysfunction and results in arterial
vasodilation via vascular smooth muscle hyperpolarization
(11). In contrast to the favorable effects of MC supplementa-
tion on the NO-dependent measures (peak brachial artery
diameter and plasma nitrite concentration), MC supplementa-
tion did not influence this NO-independent effect on basal
brachial artery diameter.
In conclusion, the results of this randomized placebo-con-
trolled, crossover study demonstrate that 4 wk of MC powder
supplementation exerted protective effects on endothelium-
dependent vasodilation after transient IR injury in overweight,
physically inactive, nonmedicated hypertensive middle-aged
men. These effects seem to be due to increased NO availability,
as evidenced by higher plasma nitrite concentration and peak
arterial diameter during the FMD measurement. This may be a
consequence of increased concentration of peroxiredoxin and
other antioxidant systems, and, hence, reduced ROS exposure.
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